Wykłady 2015

16 listopada 2015 r.
Prof. Ron de Kloet, Department of Medical Pharmacology, LACDR/LUMC, Leiden University, Netherlands.
Tytuł wykładu: "Tipping the balance to stress resilience"

22 października 2015 r.
Prof. Richard J. Noel, Director of Molecular and Genomics Core Ponce Health Sciences Univeristy Ponce Research Institute, PR, USA.
Tytuł wykładu: "HIV Nef protein as a neurotoxin that causes learning impairment and a wider inflammatory response"

Prof. Sanjay Maggirwar, Department of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry.
Tytuł wykładu: “How to protect the brain from acute HIV infection”

7 października 2015 r.
Prof. Michał Toborek, Leonard M. Miller Professor of Biochemistry and Molecular Biology, Professor and Vice-Chair for Research, Department of Biochemistry and Molecular Biology, University of Miami School of Medicine, USA.
Tytuł wykładu: "How to build a dam and profit from it: involvement of the blood-brain barrier in neurobiology of drug abuse and HIV"

25 września 2015 r.
Dr Nicola Simola, Section of Neuropsychopharmacology, Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
Tytuł wykładu: “Dopaminergic and non-dopaminergic mechanisms in the emission of rat 50-kHz ultrasonic vocalizations”

10 czerwca 2015 r.
Prof. Michael Spedding, Secretary General IUPHAR; Outgoing Chair NC-IUPHAR, Spedding Research Solutions SARL, France
Tytuł wykładu: “Evolution, stress, metabolism converge on specific brain circuits important for cognition, and psychiatric disorders”

27 kwietnia 2015 r.
Prof. Ramon Trullas, Neurobiology Unit, Instituto de Investigaciones, Biomedicas de Barcelona, Consejo Superior de Investigaciones Cientificas, CSIC, Spain.
Tytuł wykładu: “The mitochondrial DNA hypothesis of Alzheimer's disease"

19 lutego 2015 r.
Prof. Kathryn A. Cunningham, Director, UTMB Center for Addiction Research, Vice Chairman, Department of Pharmacology and Toxicology, University of Texas Medical Branch Galveston, USA.
Temat wykładu: “Phenotypic Predictors of Cocaine Addiction and Relapse: New Serotonergic Therapeutics”